Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation

Journal of Clinical Pathology

Volumn 57, Issue 8, 2004, Pages 861-866

  Xia, H H X ^b   Yang, Y ^b   Lam, S K ^b   Wong, W M ^b   Leung, S Y ^b   Yuen, S T ^b   Elia, G ^c   Wright, N A ^c   Wong, B C Y ^a,b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 6; TREFOIL PEPTIDE;

ADULT; ARTICLE; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH EPITHELIUM; STOMACH GLAND; STOMACH MUCOSA; STOMACH ULCER;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; PEPTIDES; PYLORIC ANTRUM;

EID: 4043122473     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.015487     Document Type: Article

References (41)

1. Longman RJ, Douthwaite J, Sylvester PA, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800.
2. Lee HS, Lee HK, Kim HS, et al. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001;92:1427-34.
3. Byrd JC, Yan P, Sternberg L, et al. Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 1997;113:455-64.
4. Byrd JC, Bresalier RS. Alterations in gastric mucin synthesis by Helicobacter pylori. World J Gastroenterol 2000;6:475-82.
5. Morgenstern S, Koren R, Fraser G, et al. Gastric corpus mucin expression after partial gastrectomy, in relation to colonization with Helicobacter pylori. J Clin Gastroenterol 2001;32:218-21.
6. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 2001;44:890-5.
7. Poulsom R, Wright NA. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 1993;265:G205-13.
8. Williams GR, Wright NA. Trefoil factor family domain peptides. Virchows Arch 1997;431:299-304.
9. Wright NA. Interaction of TFF with mucins: clues to their mechanism of action? Gut 2001;48:293-4.
10. Hanby AM, Poulsom R, Singh S, et al. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105:1110-16.
11. Nogueira AMMF, Machado JC, Carneiro F, et al. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J Pathol 1999;187:541-8.
12. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
13. Ho SB, Shekels LL, Toribara NW, et al. Mucin expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995;55:2681-90.
14. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, MUC6) expression. Cancer Res 1999;59:1003-7.
15. Felicity EBM, Bruce RW. Trefoil proteins: their role in normal and malignant cells. J Pathol 1997;183:4-7.
16. Machada JC, Nogueira AM, Carneiro F, et al. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000;190:437-43.
17. Wright NA, Hoffmann W, Otto WR, et al. Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett 1997;408:121-3.
18. Farrell JJ, Taupin D, Koh TJ, et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002;109:193-204.
19. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans. IARC monographs, Vol. 61. Lyon, 1994:177-241.
20. Wong BCY, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region in China: a randomized controlled trial. JAMA 2004;291:187-94.
21. Xia HHX, Wong BCY, Lam SK. Helicobacter pylori infection and gastric cancer. Asian J Surg 2001;24:217-21.
22. Hu GY, Yu BP, Dong WG, et al. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. World J Gastroenterol 2003;9:910-14.
23. Xia HHX, Kalantar J, Talley NJ, et al. Antral-type mucosa in the gastric incisura (antralization) - a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000;95:114-21.
24. Xia HHX, Zhang G-S, Talley NJ, et al. Topographic association of gastric epithelial expression of Ki-67, Bax and Bcl-2 expression with antralization in the gastric incisura, body and fundus. Am J Gastroenterol 2002;97:3123-31.
25. Wong BCY, Wong WM, Wang WH, et al. An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2001;15:505-11.
26. Dixon MF, Genta RM, Yardley JH, et al, and the participants in the International Workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
27. Rio MC, Chenard MP, Wolf C, et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991;100:375-9.
28. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
29. Alison MR, Chinery R, Poulsom R, et al. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175:405-14.
30. Otto WR, Rao J, Cox HM, et al. Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur J Biochem 1996;235:64-72.
31. Hoosein NM, Thim L, Jorgensen KH, et al. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 1989;247:303-6.
32. Xia HHX, Lam SK, Wong WM, et al. Antralization at the edge of the gastric ulcers at the gastric incisura, body and fundus: does Helicobacter pylori infection play a role? World J Gastroenterol 2003;9:1265-9.
33. Xia HHX, Talley NJ. Apaptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001;96:16-26.
34. Wong WM, Garcia SB, Poulson R, et al. Aberrant spasmolytic peptide (TFF2)-expressing cell lineage (SPEM), pseudopyloric metaplasia (PPM) and the response to gastric mucosal damage [abstract]. Gastroenterology 1999;116:G2306.
35. Hanby AM, Poulsom R, Playford RJ, et al. The mucous neck cell in the human gastric corpus: a distinctive, functional cell lineage. J Pathol 1999;187:331-7.
36. Schmidt PH, Lee JR, Joshi V, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999;79:639-46.
37. Wright NA. Mechanisms involved in gastric atrophy. In: Hunt R, Tytgat G, eds. Helicobacter pylori. Basic mechanisms to clinical cure 2000. Dordrecht: Kluwer, 2000:239-47.
38. Correa P, Miller MJS. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151-62.
39. Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
40. Yamaguchi H, Goldenring JR, Kaminishi M, et al. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 2002;47:573-8.
41. Yamaguchi H, Goldenring JR, Kaminishi M, et al. Association of spasmolytic palypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats. Lab Invest 2002;82:1045-52.